Overview
- 6 FDA inspections are on record.
- 6 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-09-05.
At a glance
Inspections
6
Form 483s
6
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 18 Aug 2025 – 5 Sep 2025 | Human Drugs | 483 | View 483 → |
| 27 Feb 2023 – 30 Mar 2023 | Human Drugs | 483 | View 483 → |
| 30 Jul 2018 – 22 Aug 2018 | Human Drugs | 483 | View 483 → |
| 29 Aug 2016 – 19 Sep 2016 | Human Drugs | 483 | View 483 → |
| 3 Feb 2015 – 11 Feb 2015 | Human Drugs | 483 | View 483 → |
| 4 Jun 2014 – 11 Jun 2014 | Human Drugs | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
5 Sep 2025
21 CFR 211.113(b)
Procedures for sterile drug products
Cited by Seneca D Toms, Luis P Torres
5 Sep 2025
21 CFR 211.165(a)
Testing and release for distribution
Cited by Seneca D Toms, Luis P Torres
5 Sep 2025
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Seneca D Toms, Luis P Torres
Investigators
FDA investigators tied to this site in the record.
Seneca D Toms1 insp.
Luis P Torres1 insp.
Jazmine N Brown1 insp.
Zhongren Wu1 insp.
Gayle S Lawson1 insp.
James M Mason1 insp.
Michael L Casner1 insp.
Junho Pak1 insp.
Vlada Matusovsky1 insp.
Kendra L Brooks1 insp.
Anita R Michael1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 7x |
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 5x |
| 21 CFR 211.167(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.165(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.28(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.56(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.113(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.142 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.186(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(iv) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Central Admixture Pharmacy Services, Inc.'s 6 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat